文献速递传染病防控与疫情报告免疫规划

英国东南部小学百日咳暴发调查及两种无细胞加强疫苗比较

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019.
PubMed 文献 · Euro Surveill · 2021-01-01

2019年3月,英格兰一所小学(7-11岁)发生百日咳暴发,学生曾在40月龄接种含百日咳成分加强疫苗。通过病例对照调查评估传播程度及3组分与5组分无细胞百日咳加强疫苗保护差异,并从口腔液检测抗百日咳毒素IgG抗体。381名学生中134名(35.2%)被判定为百日咳病例。

要点

  • 381名学生中134名(35.2%)为百日咳病例,其中133例经抗PT IgG抗体显著升高判定。
  • 接种3组分(33.7%)或5组分(32.3%)aP加强疫苗的学生百日咳风险无显著差异。
  • 不同年级百日咳感染率差异显著,3至6年级分别为22.9%、50.0%、23.7%、38.1%。

核心结论

  • 3组分与5组分aP加强疫苗在预防百日咳方面未见显著保护差异。
  • 学校内百日咳传播可能与学生疫苗接种记录不完整有关。

研究设计与样本

  • 病例对照调查,对象为英格兰东南部一所小学7-11岁学生。
  • 采集学生口腔液检测抗百日咳毒素IgG抗体,并通过问卷和全科医生记录获取症状与疫苗接种状态。

主要发现

  • 381名学生中134名(35.2%)为百日咳病例,133例经抗PT IgG抗体显著升高判定,1例临床诊断。
  • 接种3组分aP加强疫苗的学生百日咳风险为33.7%,接种5组分者为32.3%,差异无统计学意义。
  • 3至6年级百日咳病例比例分别为22.9%、50.0%、23.7%、38.1%,年级间差异显著。
  • 疫苗接种记录不完整的学生比例高于国家报告覆盖率中未覆盖的比例。

关键数值与推荐

  • 百日咳病例判定依据抗PT IgG抗体显著升高或临床诊断。
  • 3组分aP加强疫苗接种者百日咳风险33.7%,5组分者32.3%。
  • 3至6年级百日咳病例比例分别为22.9%、50.0%、23.7%、38.1%。

临床怎么用

  • 学校百日咳暴发调查中应核实学生疫苗接种记录完整性。
  • 口腔液抗PT IgG抗体检测可用于百日咳病例的实验室确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In March 2019, a pertussis outbreak occurred in children in a junior school (7-11 years) in England who had been offered pertussis-containing booster vaccine at 40 months of age. In a case-control investigation, we assessed the extent of transmission and any difference in protection afforded to those who had previously received a booster 3- or 5-component acellular pertussis vaccine (aP). We took oral fluid specimens from the students to determine IgG antibodies against pertussis toxin (anti-PT). Parents of students attending the school were sent a questionnaire on pertussis symptoms and vaccination status was retrieved from general practitioner records for all students. Of 381 students, 134 (35.2%) were classified as pertussis cases, 133 by demonstration of significant anti-PT IgG titres and one clinically. There was no significant difference in the risk of pertussis between students receiving 3-component (33.7%) or 5-component (32.3%) aP boosters. However, pertussis infection differed significantly in school year 4, with 22.9%, 50.0%, 23.7% and 38.1% pertussis cases in years 3, 4, 5 and 6, respectively. The proportion of students with incomplete vaccinations recorded was higher than the proportion of those not covered according to the national reported coverage, possibly contributing to sustained transmission within the school.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Tessier E, Campbell H, Ribeiro S, et al. Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019. Euro Surveill. 2021. PMID: 33769247. doi:10.2807/1560-7917.ES.2021.26.12.2000244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。